Suneel Gupta, Ph.D.

Suneel Gupta, Ph.D.

Chief Development OfficeratProtagonist Therapeutics· In proxies 2022–2024

Pay in FY2024+23% from the year before · Protagonist Therapeutics stock +68.3% the same year

Suneel Gupta, Ph.D. was paid $2.7M in FY2024 (Dec), up 23%. Protagonist Therapeutics stock rose 68.3% that year.

Pay$100 in the stock at the end of FY21 → $113
Pay is from the Summary Compensation Table of each Protagonist Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Protagonist TherapeuticsPublic company · 4 yr
    • Chief Development Officer2022 – Present · 4 yrStock in role +316%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?